The indispensable role of CXCR4/CXCL12 in B-ALL development is further evidenced by a study that found that expression of phosphorylated CXCR4 in the BM correlated with poorer treatment response and shorter overall survival in adults with B-ALL [107]. The gene discussed is CXCL12; the disease is acute lymphoblastic leukemia.